| Clinical data | |
|---|---|
| Trade names | Choloxin |
| Other names | D-3,5,3',5'-tetraiodothyronine |
| AHFS/Drugs.com | Multum Consumer Information |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.000.094 |
| Chemical and physical data | |
| Formula | C15H11I4NO4 |
| Molar mass | 776.874 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Dextrothyroxine (trade nameCholoxin) is adextrorotaryisomer ofthyroxine.[1] It saw research as acholesterol-lowering drug[2] but was pulled due to cardiac side-effects. It increaseshepatic lipase which in turn improves utilization oftriglycerides and decreases levels oflipoprotein(a) inblood serum.[3]
Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it. |